Science ❯ Medical Research ❯ Vaccine Research
Funding Sources Safety Studies Vaccine Injury mRNA Technology Malaria Vaccine Trials Next-Generation Vaccines Tuberculosis Vaccine COVID-19 Vaccine Effectiveness mRNA Vaccine Trials Experimental Vaccines
The move shrinks its staff to under 5,000 by year-end to cut $1.5 billion in annual expenses by 2027.